Janssen Healthcare Innovation’s Care4Today programme is set to take two of the highest honours at the 2015 eyeforpharma Barcelona Awards as the shortlist was today announced.
Both their Orthopaedic Solutions and Heart Health Solutions initiatives are shortlisted for the ‘Most Valuable Patient’ and ‘Most Valuable HCP’ initiatives, respectively; a testament to the success of the brand’s commitment to transforming healthcare for the consumer.
The names of the shortlisted projects selected from hundreds of initiatives from Europe, Middle East, Africa and Asia/Pac, were released today and have been identified by the judging panel as the front-runners in customerinnovation and value creation in the industry.
Favouring projects which could demonstrate a real improvement in the lives of the consumer, judgeSteve Turley, Lundbeck, commented of the Heart Health Solutions programme: “this is an excellent project based on deep and meaningful insight, making a real difference for the company, HCPs, and patients”. The initiative is a comprehensive cardiac rehabilitation programme which digitises health records allowing for improved referral and recruitment of patients onto cardiac rehabilitation and providing engaging and interactive exercise programmes for patients based on real-time data.
A comprehensive list of finalists can be found online here:
http://www.eyeforpharma.com/barcelona/awards-index.php
Winners will be announced at the2nd annualeyeforpharma Barcelona Awardson Tuesday 24th March at the CCIB, Barcelona from 7.30pm, as part of the largest gathering of pharma executives, eyeforpharma Barcelona. The evening will be attended by the top 200 VIPs from the pharma industry.
For more information contact Awards Manager, Chloe Leighton on
chloe@eyeforpharma.com or visit www.eyeforpharma.com/barcelona/awards
